Beyond Air (XAIR) Cash from Operations Growth (1y) (2017 - 2026)
Powered by 
Analysis
Beyond Air (XAIR) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -12.60% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | -9.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.28% |
| Mar 31, 2026 | 28.93% |
| Dec 31, 2025 | 45.44% |
| Sep 30, 2025 | 66.64% |
| Jun 30, 2025 | 55.54% |
| Mar 31, 2025 | 35.13% |
| Dec 31, 2024 | 44.03% |
| Sep 30, 2024 | 6.77% |
| Jun 30, 2024 | 40.65% |
| Mar 31, 2024 | -27.07% |
| Dec 31, 2023 | -62.38% |
| Sep 30, 2023 | -101.02% |
| Jun 30, 2023 | -150.77% |
| Mar 31, 2023 | -6.84% |
| Dec 31, 2022 | -235.06% |
| Sep 30, 2022 | -242.46% |
| Jun 30, 2022 | -74.58% |
| Mar 31, 2022 | -41.86% |
| Dec 31, 2021 | 219.68% |
| Sep 30, 2021 | 250.58% |